PharmEasy Unlisted Share (API)
₹6.2▼4.62%(0.30)
About the company
PharmEasy is an Indian digital healthcare platform that provides access to medicines, healthcare products, diagnostic tests, and other health-related services through its online platform. Founded in 2015 by Dharmil Sheth and Dr. Dhaval Shah, the company was created with the aim of making healthcare more accessible and convenient for consumers.
Through its technology-driven platform and healthcare network, PharmEasy connects customers with pharmacies, diagnostic services, and other healthcare providers, offering a convenient way to access a range of healthcare products and services across India.
Fundamentals
Valuation
| Metric | Value |
|---|---|
| 52 week high | ₹7.75 |
| 52 week low | ₹5.6 |
| P/B ratio | 0 |
| Debt to equity | N/A |
| ROE (%) | N/A |
| Book value | N/A |
| Face value | ₹1 |
52 week high
52 week low
| Metric | Value |
|---|---|
| 52 week high | ₹7.75 |
| 52 week low | ₹5.6 |
Registry
| Metric | Value |
|---|---|
| ISIN number | INE0DJ201029 |
Figures in cr ·
Financials
| P&L Statement | 2025Latest | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | 5872 | 5664 | 6644 | 5729 |
| EBITDA | -661 | -646 | -1421 | -2345 |
| OPM | -11.26 | -11.41 | -21.39 | -40.93 |
| PBT | -1517 | -2522 | -5196 | -3977 |
| PAT | -1572 | -2533 | -5211 | -3999 |
| EPS | -2.26 | -3.9 | -8.48 | -6.51 |
Shareholding Pattern
Naspers Ventures B. V
MacRitchie Investments Pte. Ltd.
TPG Growth V SF Markets Pte. Ltd.
Evermed Holding Pte. Ltd
Others
| Holder | Percentage |
|---|---|
| Naspers Ventures B. V | 12.48% |
| MacRitchie Investments Pte. Ltd. | 11.24% |
| TPG Growth V SF Markets Pte. Ltd. | 6.90% |
| Evermed Holding Pte. Ltd | 6.08% |
| Others | 63.30% |
Leadership
Frequently asked questions
Common questions on PharmEasy Unlisted Share (API)—tap a row to read the answer.
Q.1How can I buy PharmEasy Unlisted Shares?
If you're interested in buying PharmEasy unlisted shares, you generally need an active Demat account, PAN, bank account, and completed KYC. You can start by checking the current share price and availability in the unlisted market.
Once the price and quantity are agreed upon, you can complete the payment as per the transaction terms. After settlement, the shares are transferred to your Demat account. Before investing, take time to understand the company's financial performance, valuation, business prospects, and the risks involved.
Q.2How can I sell PharmEasy Unlisted Shares?
If you already own PharmEasy shares and want to sell them, you can check the current buying price and demand in the unlisted market. Once you agree on the price and quantity with a buyer, the shares can be transferred from your Demat account.
Payment is completed according to the agreed settlement process. Since these shares are not traded on a regular stock exchange, the selling price and liquidity may vary based on market conditions and buyer interest.
Q.3What is the lock-in period for PharmEasy Unlisted Shares?
Before a public listing, the shares can generally be bought and sold in the unlisted market, subject to any applicable transfer restrictions.
If PharmEasy comes out with an IPO in the future, shares acquired before the IPO may be subject to a post-listing lock-in period under the SEBI regulations applicable at that time. Investors should check the latest rules before investing or planning to sell their holdings.
Q.4How is DIS used to sell PharmEasy Unlisted Shares?
A Delivery Instruction Slip (DIS) is one way to transfer shares from your Demat account to the buyer's Demat account. It generally requires details such as the ISIN, number of shares, and recipient's Demat account information.
The completed DIS is submitted to your Depository Participant (DP) to initiate the transfer. Some DPs may also offer an electronic transfer option. Always verify the details carefully before authorizing a transaction.
Q.5What is the minimum investment required to buy PharmEasy Unlisted Shares?
The minimum investment amount depends on the current PharmEasy unlisted share price and the minimum quantity available for purchase.
Since the price and availability of shares can change over time, there may not always be a fixed minimum ticket size. It is best to check the current price, available quantity, and total investment amount before proceeding with a purchase.
Q.6Is buying PharmEasy Unlisted Shares legal in India?
Yes, buying and selling shares of an unlisted company is generally legal in India, provided the transaction is carried out in accordance with applicable laws and regulations.
Investors should complete the necessary KYC requirements, use valid bank and Demat accounts, and maintain proper records of their transactions. It is also important to conduct proper due diligence before investing.
Q.7How are short-term capital gains on PharmEasy Unlisted Shares taxed?
If you sell your shares within the holding period classified as short-term under prevailing Indian tax laws, any profit earned may be treated as a Short-Term Capital Gain (STCG).
The applicable tax treatment depends on the tax rules in effect at the time of sale and your individual circumstances. Since tax regulations may change, consider consulting a qualified tax professional for guidance specific to your situation.
Q.8How are long-term capital gains on PharmEasy Unlisted Shares taxed?
If the shares are held for the required period to qualify as a long-term capital asset before being sold, any profit earned may be treated as a Long-Term Capital Gain (LTCG).
The applicable tax rate and treatment depend on the income-tax regulations in force at the time of sale. Investors should maintain proper records of the purchase date, acquisition cost, and sale transaction for accurate tax calculation and filing.
Unlisted Trending shares
High-demand unlisted opportunities currently available for trade.
MARKET INSIGHTS & UPDATES
Read the latest updates, investment ideas, and market insights designed to help investors better understand unlisted and pre-IPO opportunities.

NSE IPO 2026: Dates, Allotment & Listing Details
The much-awaited NSE IPO is set to make a major market debut in September 2026. As per the announced schedule, the IPO will open on 21 September and close on 23 September 2026, followed by share allotment on 24 September and listing on 28 September 2026. With strong investor interest and NSE’s position as one of India’s leading market institutions, the IPO is expected to attract significant attention. Here’s a quick look at the NSE IPO 2026 timeline and important dates investors should know.

Upcoming IPOs in 2026: NSE, Rentomojo, Manipal & Pranav Guide
Four major 2026 IPOs: NSE, Manipal Payment, Rentomojo, Pranav Constructions. For pre-IPO investors, these mark critical transitions from private to public valuations. Conduct due diligence before investing.

Purple Style Labs: From Unlisted Shares to IPO - A Price Journey Worth Noticing
Purple Style Labs is making headlines as it moves from the unlisted market towards its IPO. With its unlisted shares trading around ₹500–₹525 and an IPO price band of ₹546–₹575, the price journey offers an interesting look at how private-market and IPO valuations can differ.

Muthoot FinCorp Unlisted Shares: Q1FY27 Profit Surges to ₹705 Cr | Fundamentals & IPO
Muthoot FinCorp's Q1FY27 profit surged to ₹705.48 crore as the company moves toward a proposed ₹3,000-crore IPO. Here's a look at its financial performance, valuation metrics, asset quality and key fundamentals.

From Debt to Debt-Free: How API Holdings Used Thyrocare to Reshape Its Balance Sheet
API Holdings has repaid ₹1,050 crore of debt by monetising a 9.90% stake in Thyrocare while retaining 51.02% control. Here's how the move reshapes its balance sheet and what it means going forward.

Pre IPO Shares in India: Price, How to Buy & Complete Guide
Learn what Pre IPO Shares are, how their prices are determined, how to buy them in India, and what investors should check before investing in unlisted companies.
